1. Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief Review
    S. Yuvaraj et al, 2022, Mini-Reviews in Medicinal Chemistry CrossRef
  2. Anti‐tumor effects of a nonsteroidal anti‐inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator‐activated receptor gamma and suppressing matrix metalloproteinase‐2 expression
    Takashi Higuchi et al, 2018, Cancer Medicine CrossRef
  3. Acute exposure to oil induces age and species-specific transcriptional responses in embryo-larval estuarine fish
    Elizabeth R. Jones et al, 2020, Environmental Pollution CrossRef
  4. The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs)
    Rana A. Alaaeddine et al, 2021, Current Medicinal Chemistry CrossRef
  5. Redox-Dependent Anti-Inflammatory Signaling Actions of Unsaturated Fatty Acids
    Meghan Delmastro-Greenwood et al, 2014, Annual Review of Physiology CrossRef
  6. Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS
    Shiran Salomon-Zimri et al, 2023, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration CrossRef
  7. Prenatal androgen excess alters the uterine peroxisome proliferator-activated receptor (PPAR) system
    Silvana R. Ferreira et al, 2019, Reproduction, Fertility and Development CrossRef
  8. The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
    Fabio Arturo Iannotti et al, 2021, Cells CrossRef
  9. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines
    Łukasz Uram et al, 2018, European Journal of Pharmaceutical Sciences CrossRef
  10. Prenatal testosterone exposure induces insulin resistance, uterine oxidative stress and pro-inflammatory status in rats
    Silvana Rocío Ferreira et al, 2021, Molecular and Cellular Endocrinology CrossRef
  11. Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies
    Asmaa F Khafaga et al, 2021, Nanomedicine CrossRef
  12. Celecoxib induces adipogenic differentiation of hemangioma‑derived mesenchymal stem cells through the PPAR‑γ pathway in vitro and in vivo
    Yuan Wang et al, 2022, Experimental and Therapeutic Medicine CrossRef
  13. The Association between the Usage of Non-Steroidal Anti-Inflammatory Drugs and Cognitive Status: Analysis of Longitudinal and Cross-Sectional Studies from the Global Alzheimer’s Association Interactive Network and Transcriptomic Data
    Robert Morris et al, 2020, Brain Sciences CrossRef

  14. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review


    Michael Fana et al, 2020, International Journal of Nanomedicine CrossRef
  15. Plasma-Derived Exosomes from NAFLD Patients Modulate the Cannabinoid Receptors’ Expression in Cultured HepaRG Cells
    Valentina De Nunzio et al, 2023, International Journal of Molecular Sciences CrossRef
  16. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents—Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans
    Łukasz Uram et al, 2024, International Journal of Molecular Sciences CrossRef
  17. The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro
    Łukasz Uram et al, 2019, Molecules CrossRef